Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: CANCER ; radiotherapy ; SURVIVAL ; tumor ; Germany ; TOXICITY ; FOLLOW-UP ; imaging ; DISEASE ; LONG-TERM ; SURGERY ; PATIENT ; RESPONSES ; MAGNETIC-RESONANCE ; magnetic resonance imaging ; TARGET ; NO ; stereotactic radiotherapy ; PROGRESSION ; MALIGNANCIES ; EXPERIENCE ; RADIATION-THERAPY ; TUMOR PROGRESSION ; EFFICACY ; RATES ; local control ; CHILDREN ; GLIOMAS ; MANAGEMENT ; MALIGNANCY ; ONCOLOGY ; CHILDHOOD ; RE ; CRANIOPHARYNGIOMAS ; development ; IMPAIRMENT ; methods ; fractionated stereotactic radiotherapy ; USA ; survival rate ; RESONANCE ; PRECISION ; COMBINED SURGERY ; Rathke pouch
    Abstract: BACKGROUND. The long-term outcome in patients with craniopharyngiomas treated with fractionated stereotactic radiotherapy (FSRT) was evaluated. METHODS. A total of 40 patients with craniopharyngiomas were treated between May 1989 and July 2006 with FSRT. Most patients were treated for tumor progression after surgery. A median target dose of 52.2 grays (Gy) (range, 50.4-56 Gy) was applied in a median conventional fractionation of 5 x 1.8 Gy per week. Follow-up examinations included thorough clinical assessment as well as contrast-enhanced magnetic resonance imaging scans. RESULTS. After a median follow-up of 98 months (range, 3-326 months), local control was 100% at both 5 years and 10 years. Overall survival rates at 5 years and 10 years were 97% and 139%, respectively. A complete response was observed in 4 patients and partial responses were noted in 25 patients. Eleven patients presented with stable disease during follow-up. Acute toxicity was mild in all patients. Long-term toxicity included enlargement of cysts requiring drainage 3 months after FSRT. No visual impairment, radionecrosis, or development of secondary malignancies were observed. CONCLUSIONS. The long-term outcome of FSRT for craniopharyngiomas is excellent with regard to local control as well as treatment-related side effects
    Type of Publication: Journal article published
    PubMed ID: 17469176
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...